Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIDA2000 - Risk-Adapted Therapy for APL
NCT00180128Phase 4Unknown
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2000
- Primary completion
- Nov 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of tretinoin, idarubicin, mitoxantrone, daunorubicin, cytarabine in acute promyelocytic leukemia (APL), sponsored by Technische Universität Dresden. Status: unknown.
02
Drugs
tretinoinidarubicinmitoxantronedaunorubicincytarabine
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00180128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180128.